Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

(2012) Paul M Ridker et al.   LANCET

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

(2011) P. Anagnostis et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies

(2011) Mariana Catta-Preta et al.   VIRCHOWS ARCHIV

Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia

(2010) Luca Puccetti et al.   ATHEROSCLEROSIS

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study

(2010) Christos V. Rizos et al.   CLINICAL THERAPEUTICS

Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease

(2010) S. Kaser et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet

(2010) Julio C. Fraulob et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice

(2009) Victoria J. Vieira et al.   CYTOKINE

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose

(2009) M. S. Kostapanos et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

(2008) Hideyuki Hyogo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis

(2008) N. Anderson et al.   PHARMACOLOGICAL REVIEWS

Nonalcoholic fatty liver disease and mitochondrial dysfunction

(2008) Yongzhong Wei et al.   WORLD JOURNAL OF GASTROENTEROLOGY